Skip to content

Evaluation of the Factors Associated With BRADYcardia Following Pulmonary Vein Isolation Using Pulsed Field Ablation

Evaluation of the Factors Associated With Bradtycardia Following Pulmonary Vein Isolation Using Pulsed Field Ablation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07809347
Acronym
BRADY-PFA
Enrollment
100
Registered
2026-09-09
Start date
2026-01-01
Completion date
2026-12-31
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF), Bradycardia, Pulsed Field Ablation

Brief summary

The study aims to identify factors associated with bradycardia during the hospital stay after ablation of atrial fibrillation performed with pulsed field technology.

Detailed description

The following factors will be analyzed: * demographics * medical history * medications * echocardiographic data * baseline ECG * anaesthetic records * periprocedural data

Interventions

PROCEDUREPulmonary vein isolation

Ablation of atrial fibrillation using pulsed field technology under general sedation.

Sponsors

Wroclaw Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Pulmonary vein isolation performed with PFA

Exclusion criteria

* Permanent pacemaker * CRT device * Dual-chamber ICD * Cardiac tamponade * Acute stroke * Acute bleeding requiring surgical intervention

Design outcomes

Primary

MeasureTime frame
Sinus bradycardia <50 beats/min on arrival at the recovery unit, defined as a sinus heart rate <50 beats/min on the first ECG obtained upon arrivalDay 1

Secondary

MeasureTime frame
Bradycardia requiring medical interventionDay 1
Sinus bradycardia <50 beats/min, defined as a sinus heart rate <50 beats/min on the ECG obtained the next day after ablationDay 2

Countries

Poland

Contacts

CONTACTPiotr Niewinski, MD PhD
pnsky@wp.pl+48790423298

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026